{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Trusha Adeshara",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "receptors/forest2019.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Moreover, neurodegeneration correlates best with neurofibrillary tangle burden [3]",
      "key": "70e2a0764eb4eccee0d5290ecf8fa7a0",
      "line": 78,
      "relation": "association",
      "source": 57,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Moreover, neurodegeneration correlates best with neurofibrillary tangle burden [3]",
      "key": "05ce64a21b6037807390049c32b3149d",
      "line": 78,
      "relation": "association",
      "source": 52,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Abeta is produced via sequential proteolytic cleavage of the amyloid precursor protein (APP) by the processing enzymes, gamma-secretase and beta-secretase (BACE) [14]",
      "key": "c840e1276f844a7ebbafba8fa6b83b69",
      "line": 83,
      "relation": "increases",
      "source": 31,
      "target": 35
    },
    {
      "key": "72c3fc20c0115d338330cd6ea8a32463",
      "relation": "partOf",
      "source": 22,
      "target": 31
    },
    {
      "key": "f5f0a9eabb0e06411ab8ff22b2bf2ffd",
      "relation": "partOf",
      "source": 34,
      "target": 31
    },
    {
      "key": "5efa9ea30f0b6cb4a55908d43e25d2ea",
      "relation": "hasVariant",
      "source": 34,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "a560eafa07e4cc2ad8d316e7a90a9a8c",
      "line": 90,
      "relation": "regulates",
      "source": 34,
      "target": 21
    },
    {
      "key": "2841a3bd340befb5ea6d8d024e7c8f97",
      "relation": "partOf",
      "source": 36,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Abeta is produced via sequential proteolytic cleavage of the amyloid precursor protein (APP) by the processing enzymes, gamma-secretase and beta-secretase (BACE) [14]",
      "key": "5fc548fcea5b4bd9f23cead60b8a98d1",
      "line": 84,
      "relation": "increases",
      "source": 35,
      "target": 0
    },
    {
      "key": "0e066e73596f8a3fe3785232ef630f97",
      "relation": "partOf",
      "source": 0,
      "target": 26
    },
    {
      "key": "f4ae455d145625b258a084ad712e30b5",
      "relation": "partOf",
      "source": 0,
      "target": 30
    },
    {
      "key": "d84790cecb5965607d84beeeca037eb4",
      "relation": "partOf",
      "source": 0,
      "target": 29
    },
    {
      "key": "55ca92b36cbf4cc60c084b68c87c1e5d",
      "relation": "partOf",
      "source": 0,
      "target": 28
    },
    {
      "key": "5fbd9a2acf9fdc340c3678188cde2556",
      "relation": "partOf",
      "source": 0,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin receptors were found to be regulated by Aβ [62,64] and both peptides acting via amylin receptors trigger apoptotic neuronal death [75].",
      "key": "8b17b15a8a43b6233cc0a5bbcbd0a42c",
      "line": 145,
      "relation": "regulates",
      "source": 0,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "c7b86b5a617c4a88863ec533d2d2f10a",
      "line": 188,
      "relation": "increases",
      "source": 0,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 69
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "eb6152bd146a7c450599c3ff3b100894",
      "line": 91,
      "relation": "association",
      "source": 21,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "c188725e1c73d08cc0e10f78e670c581",
      "line": 92,
      "relation": "negativeCorrelation",
      "source": 21,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "8fc1e783ee81d96520f80e52e5742091",
      "line": 93,
      "relation": "negativeCorrelation",
      "source": 21,
      "target": 54,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "b29230c0935217c17d82a1ea2e54e8c8",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 21,
      "target": 19
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "80cc25442ebc2e9638d77323e0e8c8fc",
      "line": 170,
      "relation": "association",
      "source": 21,
      "target": 9
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "c3ce61c06d4d2dda88994802c1d01384",
      "line": 171,
      "relation": "association",
      "source": 21,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "25e80ac3445623a04a381e5d971fdead",
      "line": 91,
      "relation": "association",
      "source": 23,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "b840e0088c029b1e2d8732f424d94949",
      "line": 92,
      "relation": "negativeCorrelation",
      "source": 16,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "359263b00717c2c0d49ffcdd2333d114",
      "line": 93,
      "relation": "negativeCorrelation",
      "source": 54,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Additional neuroprotective strategies relevant to AD include regulating APP [43], neurotransmitter receptors (e.g., [44]), downregulating stress kinase signaling cascades [45–47], blocking activation of caspases (e.g., [48]), and/or upregulating cell survival pathways [49–52].",
      "key": "2cdc78a7b28a8558dc7af152248d5705",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 19,
      "target": 21
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "4a9b4f013f69b1a8a95baeaf5d619320",
      "line": 167,
      "relation": "association",
      "source": 19,
      "target": 15
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "f43df79529a173856869e2a2a2017dca",
      "line": 168,
      "relation": "association",
      "source": 19,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "0108bbe4c426afda58750af0d74c8911",
      "line": 100,
      "relation": "decreases",
      "source": 59,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "7ee5cc8cdfccef522d7649b27cb1047f",
      "line": 101,
      "relation": "decreases",
      "source": 59,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "d7db4b4db5fa1bb02c31c6eafcb03846",
      "line": 102,
      "relation": "decreases",
      "source": 59,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "6693b6e8d741f8a0502e07e658d63d20",
      "line": 103,
      "relation": "decreases",
      "source": 59,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "09bea3f201d3220b0526a2e7cde55667",
      "line": 104,
      "relation": "decreases",
      "source": 59,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "6c774ce27ed31bcc0b97914e31b3723c",
      "line": 105,
      "relation": "increases",
      "source": 59,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "c4dd391cfe95c4be6eaf0e5e1d28b17c",
      "line": 106,
      "relation": "increases",
      "source": 59,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "c20fc5fe69d4996291d8256059472489",
      "line": 107,
      "relation": "increases",
      "source": 59,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "0af006f9d4ca80d842aa37a725786473",
      "line": 108,
      "relation": "increases",
      "source": 59,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Behavioral deficits in AD extend to impaired attention, orientation (space and time), working memory, executive function and judgment, language function, mood (depression, anxiety, agitation), and sleep [56].",
      "key": "d5d5b24d6659d0930dedbe17e94baa9e",
      "line": 109,
      "relation": "increases",
      "source": 59,
      "target": 62
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Hippocampus",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "In AD models, the cAMP response element-binding protein (CREB), a constitutively expressed nuclear transcription factor that regulates neuronal survival and function, has been shown to be downregulated in hippocampal neurons [50–52].",
      "key": "1101c1a850de78dbf8bfcce0aaa86d65",
      "line": 158,
      "relation": "decreases",
      "source": 59,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "1a6aaba5cf0cbaf072d9fa1abfd07f6a",
      "line": 114,
      "relation": "decreases",
      "source": 26,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "8b5063cb3639501bac0f9a5c7e3ac7ef",
      "line": 115,
      "relation": "decreases",
      "source": 26,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "76eeffb8f73711f45d5b17b2235d59d9",
      "line": 116,
      "relation": "increases",
      "source": 26,
      "target": 13
    },
    {
      "key": "f7b5ccbae4f5626eb9079ecb763b564c",
      "relation": "partOf",
      "source": 39,
      "target": 26
    },
    {
      "key": "a2fd7231f37e8c63bfb6d1d73c8d69a1",
      "relation": "partOf",
      "source": 42,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "af3380f9913d2ede2f06d7f016780117",
      "line": 117,
      "relation": "decreases",
      "source": 30,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "d8af6c0b18f9d44b9ce948f292a2f3cd",
      "line": 118,
      "relation": "decreases",
      "source": 30,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "f74bcc959482a322062bcbe91371932d",
      "line": 119,
      "relation": "increases",
      "source": 30,
      "target": 13
    },
    {
      "key": "2fa4a78010f36950b6861408129b3fa9",
      "relation": "partOf",
      "source": 53,
      "target": 30
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin was originally described as a pancreatic peptide linked to diabetes via its glycemic regulation and pancreatic β-cell dysregulation [73]; however,receptors in the brain for amylin were later discovered [74], largely linked to autonomic regulation.",
      "key": "9c0682b3f9ab6973d3e44c1a9434cbc2",
      "line": 139,
      "relation": "regulates",
      "source": 53,
      "target": 5
    },
    {
      "key": "4fd5ae41a076e122339ea430d7bfa882",
      "relation": "partOf",
      "source": 53,
      "target": 25
    },
    {
      "key": "594210cc900997cc0b386c398cfcf265",
      "relation": "partOf",
      "source": 53,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "00f78c576e21b8484a8e9dd9f19d5a17",
      "line": 120,
      "relation": "decreases",
      "source": 29,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "f1bbd531040e0383bee63f884b7adf43",
      "line": 121,
      "relation": "decreases",
      "source": 29,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "0f8a7ffed8a3b6eacac50555bacbc551",
      "line": 122,
      "relation": "increases",
      "source": 29,
      "target": 13
    },
    {
      "key": "b3b25a43dc7d1107f3b299159fcc39da",
      "relation": "partOf",
      "source": 45,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "e8569606da07b12c2f2d027adad130b1",
      "line": 123,
      "relation": "decreases",
      "source": 28,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "8acaa1eecdbe35d8962cc1d12aa8342e",
      "line": 124,
      "relation": "decreases",
      "source": 28,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "0d6e167d5c7937fb41a9352d568a5634",
      "line": 125,
      "relation": "increases",
      "source": 28,
      "target": 13
    },
    {
      "key": "46104526ead28e03a1518ae5975f26ee",
      "relation": "partOf",
      "source": 44,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "c86b72dfbd3548cbb36f917aa04793a4",
      "line": 126,
      "relation": "decreases",
      "source": 27,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "1f57a468caff2f57dc410a2606116d56",
      "line": 127,
      "relation": "decreases",
      "source": 27,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ has been shown to interact with various receptors to induce synaptic and neuronal dysfunction and death. Targets notably include cellular prion protein (PrPc) [59,60] coupled to the metabotropic glutamate receptor 5 (mGluR5) [59,61], amylin receptors [62–64], NMDA-type glutamate receptors (and perhaps AMPA glutamate receptors) [65,66], and nicotinic acetylcholine receptors (nAChRs) [67–69].",
      "key": "ce3bde85d31a06d20ea5f4328a67c283",
      "line": 128,
      "relation": "increases",
      "source": 27,
      "target": 13
    },
    {
      "key": "a2981dda39fd254d74671ed3e9717071",
      "relation": "partOf",
      "source": 43,
      "target": 27
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "pancreas",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin was originally described as a pancreatic peptide linked to diabetes via its glycemic regulation and pancreatic β-cell dysregulation [73]; however,receptors in the brain for amylin were later discovered [74], largely linked to autonomic regulation.",
      "key": "be02c868af8dafadb6b10642afb307a1",
      "line": 134,
      "relation": "regulates",
      "source": 40,
      "target": 1
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "pancreas",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin was originally described as a pancreatic peptide linked to diabetes via its glycemic regulation and pancreatic β-cell dysregulation [73]; however,receptors in the brain for amylin were later discovered [74], largely linked to autonomic regulation.",
      "key": "552e8ffece149d4fca99f27d5cef88c5",
      "line": 135,
      "relation": "association",
      "source": 40,
      "target": 60
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "pancreas",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin was originally described as a pancreatic peptide linked to diabetes via its glycemic regulation and pancreatic β-cell dysregulation [73]; however,receptors in the brain for amylin were later discovered [74], largely linked to autonomic regulation.",
      "key": "4e30fdc5e44eaf7618e1979059768e1b",
      "line": 136,
      "relation": "regulates",
      "source": 40,
      "target": 11
    },
    {
      "key": "9c1639eaade16a9133c822bddeea92ce",
      "relation": "partOf",
      "source": 40,
      "target": 25
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "pancreas",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin was originally described as a pancreatic peptide linked to diabetes via its glycemic regulation and pancreatic β-cell dysregulation [73]; however,receptors in the brain for amylin were later discovered [74], largely linked to autonomic regulation.",
      "key": "22792ae76abe9f91c182d52f814f39fe",
      "line": 135,
      "relation": "association",
      "source": 60,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin receptors were found to be regulated by Aβ [62,64] and both peptides acting via amylin receptors trigger apoptotic neuronal death [75].",
      "key": "645b0f48240c46311b726aa1c5825014",
      "line": 146,
      "relation": "increases",
      "source": 25,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Amylin receptors were found to be regulated by Aβ [62,64] and both peptides acting via amylin receptors trigger apoptotic neuronal death [75].",
      "key": "2b763c32e732f380c4b975b8f93908e8",
      "line": 147,
      "relation": "increases",
      "source": 24,
      "target": 12
    },
    {
      "key": "a8082d258977f2c7fb3ff0fdf45e2c1b",
      "relation": "partOf",
      "source": 33,
      "target": 24
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "In AD models, the cAMP response element-binding protein (CREB), a constitutively expressed nuclear transcription factor that regulates neuronal survival and function, has been shown to be downregulated in hippocampal neurons [50–52].",
      "key": "7f0b10c0a67088fb05351d9b9b6eae24",
      "line": 154,
      "relation": "regulates",
      "source": 38,
      "target": 19
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "96b099262c9f5b72787e26055c70966f",
      "line": 168,
      "relation": "association",
      "source": 38,
      "target": 19
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "Alzheimer's disease",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "In AD models, the cAMP response element-binding protein (CREB), a constitutively expressed nuclear transcription factor that regulates neuronal survival and function, has been shown to be downregulated in hippocampal neurons [50–52].",
      "key": "6c23e5108abddd8e55693842ebdce442",
      "line": 155,
      "relation": "regulates",
      "source": 38,
      "target": 8,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "30c9a967d30747532e717473e1dd002a",
      "line": 166,
      "relation": "association",
      "source": 38,
      "target": 15
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "7bbb6153703b231d37039d133dfadcc2",
      "line": 169,
      "relation": "association",
      "source": 38,
      "target": 9
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "7db17478a082cb05fe2bd23e26543774",
      "line": 171,
      "relation": "association",
      "source": 38,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Contributing to a feedforward mechanism, CREB is believed to upregulate neurotrophin expression and activity, importantly, brain derived neurotrophic factor (BDNF), which is important in modulating synaptic plasticity [81], and a neurotrophin target receptor, the tropomyosin receptor kinase receptor B (TrkB) [82]",
      "key": "6ff2274d9d2986bccd5e46e08c7f113c",
      "line": 177,
      "relation": "directlyIncreases",
      "source": 38,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Contributing to a feedforward mechanism, CREB is believed to upregulate neurotrophin expression and activity, importantly, brain derived neurotrophic factor (BDNF), which is important in modulating synaptic plasticity [81], and a neurotrophin target receptor, the tropomyosin receptor kinase receptor B (TrkB) [82]",
      "key": "d690e679b4a2554e106c61abb1eccef1",
      "line": 178,
      "relation": "directlyIncreases",
      "source": 38,
      "target": 46,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Contributing to a feedforward mechanism, CREB is believed to upregulate neurotrophin expression and activity, importantly, brain derived neurotrophic factor (BDNF), which is important in modulating synaptic plasticity [81], and a neurotrophin target receptor, the tropomyosin receptor kinase receptor B (TrkB) [82]",
      "key": "393086f13f3f768be3269f6b23b22a81",
      "line": 179,
      "relation": "directlyIncreases",
      "source": 38,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Contributing to a feedforward mechanism, CREB is believed to upregulate neurotrophin expression and activity, importantly, brain derived neurotrophic factor (BDNF), which is important in modulating synaptic plasticity [81], and a neurotrophin target receptor, the tropomyosin receptor kinase receptor B (TrkB) [82]",
      "key": "8b6cc89af585e8ac95b384c9818bd77b",
      "line": 181,
      "relation": "directlyIncreases",
      "source": 38,
      "target": 41
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "f5c14570a8813c77c66e2731365bd641",
      "line": 166,
      "relation": "association",
      "source": 15,
      "target": 38
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "08072e33954765feee3de01fe97cc0cb",
      "line": 167,
      "relation": "association",
      "source": 15,
      "target": 19
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "f6a11ff6e0f8c10c014fffdd6c487f1a",
      "line": 169,
      "relation": "association",
      "source": 9,
      "target": 38
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "It has been shown that CREB is important in neurotrophin-mediated signaling linked to neuronal survival [79] and in neuroprotection via the PI3-kinase/Akt pathway [80].",
      "key": "d3fa1ecb59b9dbcabb0d4fc6730aae36",
      "line": 170,
      "relation": "association",
      "source": 9,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Contributing to a feedforward mechanism, CREB is believed to upregulate neurotrophin expression and activity, importantly, brain derived neurotrophic factor (BDNF), which is important in modulating synaptic plasticity [81], and a neurotrophin target receptor, the tropomyosin receptor kinase receptor B (TrkB) [82]",
      "key": "2e186107a2bc1852be89358df17b339b",
      "line": 180,
      "relation": "regulates",
      "source": 37,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "372bde0926ac04b36e334fcd8159528b",
      "line": 186,
      "relation": "decreases",
      "source": 3,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "11632de6943cb8d776a8c7de2e595bc1",
      "line": 187,
      "relation": "decreases",
      "source": 3,
      "target": 0,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "6f52dae74aa188c9dace707486aa5758",
      "line": 189,
      "relation": "decreases",
      "source": 3,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "b98280c262c52d9a1e3f2bc8c887cfff",
      "line": 190,
      "relation": "decreases",
      "source": 3,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "21fd154a108005c65f9eb4370c461eb2",
      "line": 191,
      "relation": "decreases",
      "source": 3,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "b02eafeb1d502b320d5be673899edd2f",
      "line": 192,
      "relation": "decreases",
      "source": 3,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "aabb88ffadb88a67f16115aecc6d2f4f",
      "line": 193,
      "relation": "decreases",
      "source": 3,
      "target": 7,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "5693dd41ad3cfe22160cd2d123493f5e",
      "line": 194,
      "relation": "decreases",
      "source": 3,
      "target": 6,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "f7aa71dc0ff4469b811ce0c8e4110863",
      "line": 195,
      "relation": "increases",
      "source": 3,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "An example of an intriguing crossover to AD for an orally active free radical scavenger,edaravone, originally developed for acute ischemic stroke, was discovered wherein strong reductions in Aβ-induced oxidation, APP processing, Aβ deposition, neuroinflammation, neurite and dendritic loss, and synaptic and behavioral dysfunction were observed in in vitro and in vivo APP models [83].",
      "key": "8d28848c71c579604945382a5cd6585f",
      "line": 196,
      "relation": "increases",
      "source": 3,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Collectively, the findings indicate the potential of the N terminal Aβ peptides as effective neuroprotective agents against Aβ-linked neuronal toxicity, synaptic inhibition, and behavioral deficits (Box 1).",
      "key": "5b1c3b6da73b4627638e64535c3132dc",
      "line": 236,
      "relation": "positiveCorrelation",
      "source": 18,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Aβ, primarily in monomeric form, appears to be neuroprotective [84]; but it would be difficult, if not impossible, to control the concentration and structural form of Aβ in vivo [85].",
      "key": "2d1ce976f8054d12c2f40dc933d67baa",
      "line": 201,
      "relation": "increases",
      "source": 4,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Using mutational analysis together with physiological and behavioral assays in mouse models, it was determined the hydrophilic N terminal domain of Aβ is responsible for the neuromodulatory activity of full-length Aβ [86].",
      "key": "4687bf89bf1f15be28dd6f9b7bf1250e",
      "line": 207,
      "relation": "regulates",
      "source": 51,
      "target": 48,
      "target_modifier": {
        "location": {
          "name": "Neurons",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Specifically, the N terminal Aβ fragment and the N-Aβ core rescued full length Aβ-induced mitochondrial dysfunction, oxidative stress, and apoptotic neuronal death in vitro in rodent neuron models, whether added as cotreatment or, notably, post-Aβ treatment [88].",
      "key": "b3f5036d4566c901f43f920476182dc2",
      "line": 224,
      "relation": "decreases",
      "source": 51,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Specifically, the N terminal Aβ fragment and the N-Aβ core rescued full length Aβ-induced mitochondrial dysfunction, oxidative stress, and apoptotic neuronal death in vitro in rodent neuron models, whether added as cotreatment or, notably, post-Aβ treatment [88].",
      "key": "52a7a23992b4e207bbad1b36de1ec122",
      "line": 225,
      "relation": "decreases",
      "source": 51,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Specifically, the N terminal Aβ fragment and the N-Aβ core rescued full length Aβ-induced mitochondrial dysfunction, oxidative stress, and apoptotic neuronal death in vitro in rodent neuron models, whether added as cotreatment or, notably, post-Aβ treatment [88].",
      "key": "3d929ef15eb9335488ef5769dd88c06e",
      "line": 228,
      "relation": "decreases",
      "source": 51,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Collectively, the findings indicate the potential of the N terminal Aβ peptides as effective neuroprotective agents against Aβ-linked neuronal toxicity, synaptic inhibition, and behavioral deficits (Box 1).",
      "key": "7d4db8b410b38f674d5e5599e240850a",
      "line": 235,
      "relation": "increases",
      "source": 51,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Collectively, the findings indicate the potential of the N terminal Aβ peptides as effective neuroprotective agents against Aβ-linked neuronal toxicity, synaptic inhibition, and behavioral deficits (Box 1).",
      "key": "5c47b947dc047dae7a422a49c74a9385",
      "line": 236,
      "relation": "positiveCorrelation",
      "source": 51,
      "target": 18
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Collectively, the findings indicate the potential of the N terminal Aβ peptides as effective neuroprotective agents against Aβ-linked neuronal toxicity, synaptic inhibition, and behavioral deficits (Box 1).",
      "key": "ac3c5e5fc18c320cacde5e73fb98f206",
      "line": 238,
      "relation": "decreases",
      "source": 51,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Collectively, the findings indicate the potential of the N terminal Aβ peptides as effective neuroprotective agents against Aβ-linked neuronal toxicity, synaptic inhibition, and behavioral deficits (Box 1).",
      "key": "d7db1fda52970b1bf3eaa54678cb3009",
      "line": 240,
      "relation": "increases",
      "source": 51,
      "target": 17
    },
    {
      "key": "a3d555456bb1df0e486b8b78a48d6fcf",
      "relation": "hasVariant",
      "source": 48,
      "target": 51
    },
    {
      "key": "ebe0906294037fab36b15da6470fc6fe",
      "relation": "partOf",
      "source": 48,
      "target": 32
    },
    {
      "key": "9543429d82b023f44a1157b344b80eb4",
      "relation": "hasVariant",
      "source": 48,
      "target": 49
    },
    {
      "key": "77f804ce5f2b0a3d7ea4126d954bed4f",
      "relation": "hasVariant",
      "source": 48,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Specifically, the N terminal Aβ fragment and the N-Aβ core rescued full length Aβ-induced mitochondrial dysfunction, oxidative stress, and apoptotic neuronal death in vitro in rodent neuron models, whether added as cotreatment or, notably, post-Aβ treatment [88].",
      "key": "dcc10246cbf23a41726dc44965923e60",
      "line": 226,
      "relation": "increases",
      "source": 48,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Specifically, the N terminal Aβ fragment and the N-Aβ core rescued full length Aβ-induced mitochondrial dysfunction, oxidative stress, and apoptotic neuronal death in vitro in rodent neuron models, whether added as cotreatment or, notably, post-Aβ treatment [88].",
      "key": "86aba32807d9d762ccf3346c09cc68c4",
      "line": 227,
      "relation": "increases",
      "source": 48,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Specifically, the N terminal Aβ fragment and the N-Aβ core rescued full length Aβ-induced mitochondrial dysfunction, oxidative stress, and apoptotic neuronal death in vitro in rodent neuron models, whether added as cotreatment or, notably, post-Aβ treatment [88].",
      "key": "9024c57a178ce0903a7f158e8765e86b",
      "line": 229,
      "relation": "decreases",
      "source": 48,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Consequently, a nontoxic fragment of Aβ (1–15/16) that is derived from the N terminal domain, naturally derived from Aβ by the action of α-secretase, and does not oligomerize [87], was shown to be more effective in regard to neuromodulatory activity compared with that observed for Aβ [86].",
      "key": "2a7927f737749c19fe6c29bc50331a57",
      "line": 213,
      "relation": "increases",
      "source": 32,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Consequently, a nontoxic fragment of Aβ (1–15/16) that is derived from the N terminal domain, naturally derived from Aβ by the action of α-secretase, and does not oligomerize [87], was shown to be more effective in regard to neuromodulatory activity compared with that observed for Aβ [86].",
      "key": "3ccaab4950d350a4e9e8556b38a4705c",
      "line": 214,
      "relation": "increases",
      "source": 32,
      "target": 50
    },
    {
      "key": "20173c9cd39c3aa0b0c8935fc249a977",
      "relation": "partOf",
      "source": 47,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Consequently, a nontoxic fragment of Aβ (1–15/16) that is derived from the N terminal domain, naturally derived from Aβ by the action of α-secretase, and does not oligomerize [87], was shown to be more effective in regard to neuromodulatory activity compared with that observed for Aβ [86].",
      "key": "7a978f9ebe88ec751390ea570505ba24",
      "line": 215,
      "relation": "decreases",
      "source": 49,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Consequently, a nontoxic fragment of Aβ (1–15/16) that is derived from the N terminal domain, naturally derived from Aβ by the action of α-secretase, and does not oligomerize [87], was shown to be more effective in regard to neuromodulatory activity compared with that observed for Aβ [86].",
      "key": "3d1fbe54f5ffe009bd119433e79b4466",
      "line": 217,
      "relation": "regulates",
      "source": 49,
      "target": 48,
      "target_modifier": {
        "location": {
          "name": "Neurons",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Consequently, a nontoxic fragment of Aβ (1–15/16) that is derived from the N terminal domain, naturally derived from Aβ by the action of α-secretase, and does not oligomerize [87], was shown to be more effective in regard to neuromodulatory activity compared with that observed for Aβ [86].",
      "key": "e3091be1ec99e85544175e8c9e1f6d80",
      "line": 216,
      "relation": "decreases",
      "source": 50,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Forest KH",
          "Nichols RA"
        ],
        "date": "2019-08-01",
        "first": "Forest KH",
        "identifier": "31248781",
        "journal": "Trends in molecular medicine",
        "last": "Nichols RA",
        "name": "Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.",
        "namespace": "pubmed",
        "pages": "685-695",
        "volume": "25"
      },
      "evidence": "Consequently, a nontoxic fragment of Aβ (1–15/16) that is derived from the N terminal domain, naturally derived from Aβ by the action of α-secretase, and does not oligomerize [87], was shown to be more effective in regard to neuromodulatory activity compared with that observed for Aβ [86].",
      "key": "bf80add532f4564577dd873bdeb78f78",
      "line": 218,
      "relation": "regulates",
      "source": 50,
      "target": 48,
      "target_modifier": {
        "location": {
          "name": "Neurons",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      }
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:amyloid-beta)",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1bc8499994bfdd953f21795fb20a70bc"
    },
    {
      "bel": "a(CHEBI:glucose)",
      "concept": {
        "name": "glucose",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8b4d8974cf8c0e5830f78bb44168cf4d"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta oligomers\")",
      "concept": {
        "name": "amyloid-beta oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "34014daa17e0fc6d25c4a657cd071f3a"
    },
    {
      "bel": "a(DRUGBANK:Edaravone)",
      "concept": {
        "name": "Edaravone",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "82a11bfa927d0e1b7043d57415663455"
    },
    {
      "bel": "a(MESH:\"Amyloid beta-Peptides\")",
      "concept": {
        "name": "Amyloid beta-Peptides",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1db1ada7870d4670fee87d49811c18f1"
    },
    {
      "bel": "a(MESH:\"Autonomic Nervous System\")",
      "concept": {
        "name": "Autonomic Nervous System",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "295543cef9942212ac29f5df99ce9df2"
    },
    {
      "bel": "a(MESH:Dendrites)",
      "concept": {
        "name": "Dendrites",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4358e98b2ef03546daccffc5f9017aa5"
    },
    {
      "bel": "a(MESH:Neurites)",
      "concept": {
        "name": "Neurites",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "192f89a6158de53e2d132cdabb1553da"
    },
    {
      "bel": "a(MESH:Neurons)",
      "concept": {
        "name": "Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c429b8780142c504cf23cacfc2fa2b09"
    },
    {
      "bel": "bp(CONSO:\"PI3K-Akt signaling pathway\")",
      "concept": {
        "name": "PI3K-Akt signaling pathway",
        "namespace": "CONSO"
      },
      "function": "BiologicalProcess",
      "id": "288496518c9a4d85d363ac156833d945"
    },
    {
      "bel": "bp(GO:\"learning or memory\")",
      "concept": {
        "name": "learning or memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f7990d886000f2ae69441a960a7d6236"
    },
    {
      "bel": "bp(GO:\"negative regulation of type B pancreatic cell development\")",
      "concept": {
        "name": "negative regulation of type B pancreatic cell development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e9a83c83fef463c73edeb8f3ef059210"
    },
    {
      "bel": "bp(GO:\"neuron apoptotic process\")",
      "concept": {
        "name": "neuron apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d73c31b799210c2ae76d3426d593149c"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"neuronal signal transduction\")",
      "concept": {
        "name": "neuronal signal transduction",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "2f4dbcfb8c513ef96e410be6f1f5b973"
    },
    {
      "bel": "bp(GO:\"neurotrophin signaling pathway\")",
      "concept": {
        "name": "neurotrophin signaling pathway",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "7aa548f05a3c89653d38f20b3ce3f686"
    },
    {
      "bel": "bp(GO:\"stress-activated protein kinase signaling cascade\")",
      "concept": {
        "name": "stress-activated protein kinase signaling cascade",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "906009290fc868ab497e8e415e1e1ed2"
    },
    {
      "bel": "bp(GO:\"synaptic signaling\")",
      "concept": {
        "name": "synaptic signaling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "47e244f71f5d21a426ba920c40e7b9ed"
    },
    {
      "bel": "bp(GO:behavior)",
      "concept": {
        "name": "behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "77f1822074b59deb82cc4661eb6d5aa5"
    },
    {
      "bel": "bp(MESH:\"Cell Survival\")",
      "concept": {
        "name": "Cell Survival",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "c6f26bea83787c63169a3fcb728da799"
    },
    {
      "bel": "bp(MESH:\"Neuronal Plasticity\")",
      "concept": {
        "name": "Neuronal Plasticity",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "7e5d48cf7a27a09a15d969d961c71347"
    },
    {
      "bel": "bp(MESH:Neuroprotection)",
      "concept": {
        "name": "Neuroprotection",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "94345c5831649e39b0f93286f5357249"
    },
    {
      "bel": "complex(CONSO:gamma-secretase)",
      "concept": {
        "name": "gamma-secretase",
        "namespace": "CONSO"
      },
      "function": "Complex",
      "id": "6ca9572b567517b84111d2aebcd1dc91"
    },
    {
      "bel": "complex(GO:\"neurotransmitter receptor complex\")",
      "concept": {
        "name": "neurotransmitter receptor complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "6de7fdfca63cdf74fab7a6f0d7b9823d"
    },
    {
      "bel": "complex(p(CHEBI:amyloid-beta), p(MESH:\"Receptors, Islet Amyloid Polypeptide\"))",
      "function": "Complex",
      "id": "9b17d305efea888c9b8636301fd12ebe",
      "members": [
        {
          "bel": "p(CHEBI:amyloid-beta)",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Protein",
          "id": "c49f543a69bb3438d2fd2dd802f7b15f"
        },
        {
          "bel": "p(MESH:\"Receptors, Islet Amyloid Polypeptide\")",
          "concept": {
            "name": "Receptors, Islet Amyloid Polypeptide",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "f46fb391fcc6c977731b87f9382ff434"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:IAPP), p(MESH:\"Receptors, Islet Amyloid Polypeptide\"))",
      "function": "Complex",
      "id": "80c0d6ba8859ad15069582045f810c55",
      "members": [
        {
          "bel": "p(HGNC:IAPP)",
          "concept": {
            "name": "IAPP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "772b24fa8b87e261d3d5735d276f511f"
        },
        {
          "bel": "p(MESH:\"Receptors, Islet Amyloid Polypeptide\")",
          "concept": {
            "name": "Receptors, Islet Amyloid Polypeptide",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "f46fb391fcc6c977731b87f9382ff434"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:amyloid-beta), p(HGNC:GRM5), p(HGNC:PRNP))",
      "function": "Composite",
      "id": "262e049bc0a549b64177a8551b321e6f",
      "members": [
        {
          "bel": "a(CHEBI:amyloid-beta)",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "1bc8499994bfdd953f21795fb20a70bc"
        },
        {
          "bel": "p(HGNC:GRM5)",
          "concept": {
            "name": "GRM5",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "19f093133fdf1bb1564cbcbe351d9156"
        },
        {
          "bel": "p(HGNC:PRNP)",
          "concept": {
            "name": "PRNP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "0df8caec1eedc2d8cf6b578ada69c73f"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:amyloid-beta), p(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\"))",
      "function": "Composite",
      "id": "2ae832364bf14334e5fc12f37daf1266",
      "members": [
        {
          "bel": "a(CHEBI:amyloid-beta)",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "1bc8499994bfdd953f21795fb20a70bc"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
          "concept": {
            "name": "Cholinergic receptors nicotinic subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "8038209bc0b5bd919a7208d644f913f8"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:amyloid-beta), p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\"))",
      "function": "Composite",
      "id": "d7274d2a06ef82c64c486a8dd7404f9a",
      "members": [
        {
          "bel": "a(CHEBI:amyloid-beta)",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "1bc8499994bfdd953f21795fb20a70bc"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\")",
          "concept": {
            "name": "Glutamate ionotropic receptor AMPA type subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "2b014fdb0e42ce7d4f844ac1d4fe4f83"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:amyloid-beta), p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor NMDA type subunits\"))",
      "function": "Composite",
      "id": "0256858249735c59ca7d01d00b884d98",
      "members": [
        {
          "bel": "a(CHEBI:amyloid-beta)",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "1bc8499994bfdd953f21795fb20a70bc"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor NMDA type subunits\")",
          "concept": {
            "name": "Glutamate ionotropic receptor NMDA type subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "b7afccdb6102ed56132b102ce2e5f6e6"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:amyloid-beta), p(MESH:\"Receptors, Islet Amyloid Polypeptide\"))",
      "function": "Composite",
      "id": "d6fa349ed25d56f0d9f8bd4b112a9360",
      "members": [
        {
          "bel": "a(CHEBI:amyloid-beta)",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "1bc8499994bfdd953f21795fb20a70bc"
        },
        {
          "bel": "p(MESH:\"Receptors, Islet Amyloid Polypeptide\")",
          "concept": {
            "name": "Receptors, Islet Amyloid Polypeptide",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "f46fb391fcc6c977731b87f9382ff434"
        }
      ]
    },
    {
      "bel": "composite(complex(CONSO:gamma-secretase), p(HGNC:APP), p(HGNC:BACE1))",
      "function": "Composite",
      "id": "acee767bf5b91b4ccf4d17dc9f5e3e82",
      "members": [
        {
          "bel": "complex(CONSO:gamma-secretase)",
          "concept": {
            "name": "gamma-secretase",
            "namespace": "CONSO"
          },
          "function": "Complex",
          "id": "6ca9572b567517b84111d2aebcd1dc91"
        },
        {
          "bel": "p(HGNC:APP)",
          "concept": {
            "name": "APP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d43ae551265c6b6a27038d0b036848cf"
        },
        {
          "bel": "p(HGNC:BACE1)",
          "concept": {
            "name": "BACE1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "334dd03e9a5f223f13995e497b1c156e"
        }
      ]
    },
    {
      "bel": "composite(p(MESH:\"Amyloid Precursor Protein Secretases\"), p(MESH:\"Amyloid beta-Peptides\"))",
      "function": "Composite",
      "id": "9ae95292a6e0a42a24244eb7c8dc0003",
      "members": [
        {
          "bel": "p(MESH:\"Amyloid Precursor Protein Secretases\")",
          "concept": {
            "name": "Amyloid Precursor Protein Secretases",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "9fd73a5cf2d0a2bc2ef5d992e16c496e"
        },
        {
          "bel": "p(MESH:\"Amyloid beta-Peptides\")",
          "concept": {
            "name": "Amyloid beta-Peptides",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "3928201d140842a4fc21ce71a9d4010b"
        }
      ]
    },
    {
      "bel": "p(CHEBI:amyloid-beta)",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Protein",
      "id": "c49f543a69bb3438d2fd2dd802f7b15f"
    },
    {
      "bel": "p(HGNC:APP)",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d43ae551265c6b6a27038d0b036848cf"
    },
    {
      "bel": "p(HGNC:APP, frag(\"?\"))",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1d7a8a2d778541f6083221fa6bb73dec",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "334dd03e9a5f223f13995e497b1c156e"
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:CREBBP)",
      "concept": {
        "name": "CREBBP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "46148e81658994544d74b5db695e5cd8"
    },
    {
      "bel": "p(HGNC:GRM5)",
      "concept": {
        "name": "GRM5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "19f093133fdf1bb1564cbcbe351d9156"
    },
    {
      "bel": "p(HGNC:IAPP)",
      "concept": {
        "name": "IAPP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "772b24fa8b87e261d3d5735d276f511f"
    },
    {
      "bel": "p(HGNC:NTRK2)",
      "concept": {
        "name": "NTRK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5873dc57711d54aff73ef2aa04a42017"
    },
    {
      "bel": "p(HGNC:PRNP)",
      "concept": {
        "name": "PRNP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0df8caec1eedc2d8cf6b578ada69c73f"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
      "concept": {
        "name": "Cholinergic receptors nicotinic subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "8038209bc0b5bd919a7208d644f913f8"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\")",
      "concept": {
        "name": "Glutamate ionotropic receptor AMPA type subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "2b014fdb0e42ce7d4f844ac1d4fe4f83"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor NMDA type subunits\")",
      "concept": {
        "name": "Glutamate ionotropic receptor NMDA type subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "b7afccdb6102ed56132b102ce2e5f6e6"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Neurotrophins)",
      "concept": {
        "name": "Neurotrophins",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "e26616e373fcca197a60899b2c4e0af2"
    },
    {
      "bel": "p(MESH:\"Amyloid Precursor Protein Secretases\")",
      "concept": {
        "name": "Amyloid Precursor Protein Secretases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "9fd73a5cf2d0a2bc2ef5d992e16c496e"
    },
    {
      "bel": "p(MESH:\"Amyloid beta-Peptides\")",
      "concept": {
        "name": "Amyloid beta-Peptides",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "3928201d140842a4fc21ce71a9d4010b"
    },
    {
      "bel": "p(MESH:\"Amyloid beta-Peptides\", frag(\"1_15\"))",
      "concept": {
        "name": "Amyloid beta-Peptides",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "55d87984237438201c0b7817539cb36b",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 15
        }
      ]
    },
    {
      "bel": "p(MESH:\"Amyloid beta-Peptides\", frag(\"1_16\"))",
      "concept": {
        "name": "Amyloid beta-Peptides",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "61d83aaebcc8ad74f6bdb6ba924ec2f7",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 16
        }
      ]
    },
    {
      "bel": "p(MESH:\"Amyloid beta-Peptides\", frag(\"1_?\"))",
      "concept": {
        "name": "Amyloid beta-Peptides",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "e61c2f101d637e44ab6e5b29e518b5e9",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": "?"
        }
      ]
    },
    {
      "bel": "p(MESH:\"Neurofibrillary Tangles\")",
      "concept": {
        "name": "Neurofibrillary Tangles",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "23b57fa4c2111fd8150d349cd2c5c2d0"
    },
    {
      "bel": "p(MESH:\"Receptors, Islet Amyloid Polypeptide\")",
      "concept": {
        "name": "Receptors, Islet Amyloid Polypeptide",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "f46fb391fcc6c977731b87f9382ff434"
    },
    {
      "bel": "p(MESH:Caspases)",
      "concept": {
        "name": "Caspases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "4b8cd4adfc83420a440aec92462dc0b7"
    },
    {
      "bel": "path(CONSO:\"APP processing\")",
      "concept": {
        "name": "APP processing",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "e79eeb1b46bdb3a8058450313f7064d3"
    },
    {
      "bel": "path(CONSO:\"mitochondrial dysfunction\")",
      "concept": {
        "name": "mitochondrial dysfunction",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "14a330b2e354b7af4f380b05664a5728"
    },
    {
      "bel": "path(CONSO:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "e18248b0d7323caa29b448e45437a1e5"
    },
    {
      "bel": "path(CONSO:neuroinflammation)",
      "concept": {
        "name": "neuroinflammation",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "b264621022ed4df78748c6c4e198145d"
    },
    {
      "bel": "path(DOID:\"Alzheimer's disease\")",
      "concept": {
        "name": "Alzheimer's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bab8638a4ae2b144ee036438e0a858da"
    },
    {
      "bel": "path(DOID:\"diabetes mellitus\")",
      "concept": {
        "name": "diabetes mellitus",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "938cd6abfb7292beb1567c134a06833b"
    },
    {
      "bel": "path(DOID:\"mental depression\")",
      "concept": {
        "name": "mental depression",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "444223db67421fa96923920d0a8fd533"
    },
    {
      "bel": "path(DOID:\"sleep disorder\")",
      "concept": {
        "name": "sleep disorder",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "16b2af38a96cf5c3aed64dfd51512de6"
    },
    {
      "bel": "path(HP:\"Ischemic stroke\")",
      "concept": {
        "name": "Ischemic stroke",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "50cfd5a1cf06b79013af39a75b8ceca5"
    },
    {
      "bel": "path(HP:Agitation)",
      "concept": {
        "name": "Agitation",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "db336c699f840cf5228a8a4a7eb05346"
    },
    {
      "bel": "path(MESH:\"Anxiety Disorders\")",
      "concept": {
        "name": "Anxiety Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ec49ebadb24f24cc0c46b810c82f0f78"
    },
    {
      "bel": "path(MESH:\"Cell Death\")",
      "concept": {
        "name": "Cell Death",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e272f89e4ce648a10de7de994d3e1f31"
    },
    {
      "bel": "path(MESH:\"Executive Function\")",
      "concept": {
        "name": "Executive Function",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "cf426453e61e2674d5e1e153c4463cd3"
    },
    {
      "bel": "path(MESH:\"Language Disorders\")",
      "concept": {
        "name": "Language Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "619153f2baea94f9174cc1c4763b5d7a"
    },
    {
      "bel": "path(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5d5071d9dea362c9b9b6ee5de9eb67be"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "concept": {
        "name": "Plaque, Amyloid",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ff45c3caeb411cd232d96d6ed01854d5"
    },
    {
      "bel": "path(MESH:Attention)",
      "concept": {
        "name": "Attention",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f22e7196f5d0614ad79325e3690466ec"
    },
    {
      "bel": "path(MESH:Judgment)",
      "concept": {
        "name": "Judgment",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e03e69b05f06c798b9bdbdf3c8415913"
    },
    {
      "bel": "path(MESH:Orientation)",
      "concept": {
        "name": "Orientation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "73435bce21936d7f088fb9f9a5684fce"
    }
  ]
}